Journal of Internal Medicine Concepts & Practice ›› 2021, Vol. 16 ›› Issue (06): 418-421.doi: 10.16138/j.1673-6087.2021.06.010
• Review article • Previous Articles Next Articles
Received:
2021-04-16
Online:
2021-12-27
Published:
2022-07-25
CLC Number:
[1] | International Diabetes Federation. IDF diabetes atlas.[DB/OL]. 8th ed. 2019. https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. |
[2] | 卢苇, 关历, 凌仲春, 等. 浅述2型糖尿病的发病机制[J]. 影像研究与医学应用, 2017, 1(9): 168-170. |
[3] |
Bauer KC, Huus KE, Finlay BB. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis[J]. Cell Microbiol, 2016, 18(5): 632-644.
doi: 10.1111/cmi.12585 URL |
[4] |
Romijn JA, Corssmit EP, Havekes LM, et al. Gut-brain axis[J]. Curr Opin Clin Nutr Metab Care, 2008, 11(4): 518-521.
doi: 10.1097/MCO.0b013e328302c9b0 URL |
[5] |
Westfall S, Lomis N, Kahouli I, et al. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis[J]. Cell Mol Life Sci, 2017, 74(20): 3769-3787.
doi: 10.1007/s00018-017-2550-9 pmid: 28643167 |
[6] |
Depoortere I. Taste receptors of the gut: emerging roles in health and disease[J]. Gut, 2014, 63(1): 179-190.
doi: 10.1136/gutjnl-2013-305112 pmid: 24131638 |
[7] |
Giuffrè M, Moretti R, Campisciano G, et al. You talking to me? Says the enteric nervous system (ENS) to the microbe. How intestinal microbes interact with the ENS[J]. J Clin Med, 2020, 9(11): 3705.
doi: 10.3390/jcm9113705 URL |
[8] |
Fournel A, Drougard A, Duparc T, et al. Apelin targets gut contraction to control glucose metabolism via the brain[J]. Gut, 2017, 66(2): 258-269.
doi: 10.1136/gutjnl-2015-310230 pmid: 26565000 |
[9] |
Grasset E, Burcelin R. The gut microbiota to the brain axis in the metabolic control[J]. Rev Endocr Metab Disord, 2019, 20(4): 427-438.
doi: 10.1007/s11154-019-09511-1 URL |
[10] |
Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013.
doi: 10.1152/physrev.00018.2018 pmid: 31460832 |
[11] |
Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis[J]. Front Neurosci, 2018, 12: 49.
doi: 10.3389/fnins.2018.00049 URL |
[12] |
Sjölund K, Sandén G, Håkanson R, et al. Endocrine cells in human intestine: an immunocytochemical study[J]. Gastroenterology, 1983, 85(5): 1120-1130.
pmid: 6194039 |
[13] |
Andrews ZB, Liu ZW, Walllingford N, et al. UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals[J]. Nature, 2008, 454(7206): 846-851.
doi: 10.1038/nature07181 URL |
[14] |
Poher AL, Tschöp MH, Müller TD. Ghrelin regulation of glucose metabolism[J]. Peptides, 2018, 100: 236-242.
doi: 10.1016/j.peptides.2017.12.015 URL |
[15] | Tran KL, Park YI, Pandya S, et al. Overview of glucagon-like peptide-1 receptor agonists for the treatment of patients with type 2 diabetes[J]. Am Health Drug Benefits, 2017, 10(4): 178-188. |
[16] |
Samms RJ, Coghlan MP, Sloop KW. How may GIP enhance the therapeutic efficacy of GLP-1?[J]. Trends Endocrinol Metab, 2020, 31(6): 410-421.
doi: 10.1016/j.tem.2020.02.006 URL |
[17] |
Thomas MK, Nikooienejad A, Bray R, et al. Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes[J]. J Clin Endocrinol Metab, 2021, 106(2): 388-396.
doi: 10.1210/clinem/dgaa863 URL |
[18] |
Nyborg NCB, Kirk RK, de Boer AS, et al. Cholecystokinin-1 receptor agonist induced pathological findings in the exocrine pancreas of non-human primates[J]. Toxicol Appl Pharmacol, 2020, 399: 115035.
doi: 10.1016/j.taap.2020.115035 URL |
[19] | Ahrén B, Holst JJ, Efendic S. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes[J]. J Clin Endocrinol Metab, 2000, 85(3): 1043-1048. |
[20] |
Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB[J]. Physiol Rev, 2017, 97(1): 411-463.
doi: 10.1152/physrev.00031.2014 pmid: 28003328 |
[21] |
Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis[J]. Adv Exp Med Biol, 2014, 817: 195-219.
doi: 10.1007/978-1-4939-0897-4_9 pmid: 24997035 |
[22] |
Li X, Hu J, Zhang R, et al. Urocortin ameliorates diabetic nephropathy in obese db/db mice[J]. Br J Pharmacol, 2008, 154(5): 1025-1034.
doi: 10.1038/bjp.2008.155 URL |
[23] |
Tirabassi G, Corona G, Lamonica GR, et al. Diabetes mellitus-associated functional hypercortisolism impairs sexual function in male late-onset hypogonadism[J]. Horm Metab Res, 2016, 48(1): 48-53.
doi: 10.1055/s-0035-1548870 pmid: 25951320 |
[24] |
Farzi A, Hassan AM, Zenz G, et al. Diabesity and mood disorders: multiple links through the microbiota-gut-brain axis[J]. Mol Aspects Med, 2019, 66: 80-93.
doi: 10.1016/j.mam.2018.11.003 URL |
[25] |
Larraufie P, Martin-Gallausiaux C, Lapaque N, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells[J]. Sci Rep, 2018, 8(1): 74.
doi: 10.1038/s41598-017-18259-0 pmid: 29311617 |
[26] |
Xu Y, Zhou H, Zhu Q. The impact of microbiota-gut-brain axis on diabetic cognition impairment[J]. Front Aging Neurosci, 2017, 9: 106.
doi: 10.3389/fnagi.2017.00106 URL |
[27] |
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood[J]. Gastroenterology, 2021, 160(5): 1486-1501.
doi: 10.1053/j.gastro.2020.10.066 pmid: 33493503 |
[28] |
Martin AM, Yabut JM, Choo JM, et al. The gut microbiome regulates host glucose homeostasis via peripheral serotonin[J]. Proc Natl Acad Sci U S A, 2019, 116(40): 19802-19804.
doi: 10.1073/pnas.1909311116 pmid: 31527237 |
[29] |
Wu J, Wang K, Wang X, et al. The role of the gut microbiome and its metabolites in metabolic diseases[J]. Protein Cell, 2021, 12(5): 360-373.
doi: 10.1007/s13238-020-00814-7 URL |
[30] |
Gu Y, Wang X, Li J, et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment[J]. Nat Commun, 2017, 8(1): 1785.
doi: 10.1038/s41467-017-01682-2 URL |
[31] |
Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase[J]. Nat Med, 2012, 18(9): 1407-1412.
pmid: 22863787 |
[32] | American Diabetes Association. Standards of medical care in diabetes—2013[J]. Diabetes Care, 2013, 36 Suppl 1: S11-S66. |
[33] |
Ferracini M, Martins JO, Campos MR, et al. Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the FcγR signaling cascade[J]. Mol Immunol, 2010, 47(11-12): 1974-1980.
doi: 10.1016/j.molimm.2010.04.018 pmid: 20510456 |
[1] | LU Lin, DAI Yang, WANG Xiaoqun, et al. Several advances of translational research in cardiovascular diseases [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 369-372. |
[2] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 349-352. |
[3] | XU Qing, SHAO Huiying, CHEN Shuai, QUAN Jinwei, ZHOU Qingfen, WANG Minhui. The tele-nursing education and guidance ameliorate coronary plaque progression in patients with type 2 diabetes mellitus [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 330-333. |
[4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 344-348. |
[5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 373-375. |
[6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 376-380. |
[7] | SUN Yan, DAI Danjiao, CHEN Zhiwei, ZHANG Huaqing. Effect of canagliflozin on urinary albumin / creatinine ratio and urinary podocyte-associated protein nephrin in patients with early diabetic kidney disease [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 387-391. |
[8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 422-426. |
[9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 129-130. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||